Literature DB >> 10772993

Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein.

T Takimoto1, G L Taylor, S J Crennell, R A Scroggs, A Portner.   

Abstract

The hemagglutinin-neuraminidase (HN) glycoprotein of Newcastle disease virus was isolated by cleaving HN (cHN) from reconstituted virosome with chymotrypsin. N-terminal sequence analysis of the purified cHN showed that chymotrypsin cleavage had occurred at amino acid 123, freeing the C-terminal 454 amino acids. The purified cHN retained its neuraminidase and receptor binding activities and reacted with specific monoclonal antibodies, showing that the isolated cHN was biologically and antigenically functional. The crystals of the cHN were obtained in acetate buffer (pH 4.6) containing polyethylene glycol 3350 and ammonium sulfate and belong to the orthorhombic space group P2(1)2(1)2(1) with unit cell dimension of approximately a = 72 A, b = 78 A, and c = 198 A. Crystals of cHN grown in the presence of sialic acid (Neu5Ac) were grown in HEPES buffer (pH 6.2) containing polyethylene glycol 3350 and belong to the hexagonal space groups P6(1) or P6(5) with unit cell dimensions of a = b = 137.5 A and c = 116.6A. The orthorhombic crystals produced in this study diffract X rays to at least 2.0-A resolution, thereby setting the stage for the solution of the three-dimensional structure of the HN glycoprotein of a paramyxovirus. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772993     DOI: 10.1006/viro.2000.0263

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  26 in total

1.  Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion.

Authors:  Helen Connaris; Toru Takimoto; Rupert Russell; Susan Crennell; Ibrahim Moustafa; Allen Portner; Garry Taylor
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion.

Authors:  Toru Takimoto; Garry L Taylor; Helen C Connaris; Susan J Crennell; Allen Portner
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.

Authors:  Irina V Alymova; Allen Portner; Toru Takimoto; Kelli L Boyd; Y Sudhakara Babu; Jonathan A McCullers
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Effect of hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 on growth and pathogenicity of Sendai/human parainfluenza type 3 chimera virus in mice.

Authors:  Makiko Watanabe; Vasiliy P Mishin; Scott A Brown; Charles J Russell; Kelli Boyd; Y Sudhakara Babu; Garry Taylor; Xiaoping Xiong; Xiaowei Yan; Allen Portner; Irina V Alymova
Journal:  Antimicrob Agents Chemother       Date:  2009-06-29       Impact factor: 5.191

5.  Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk.

Authors:  Ping Yuan; Kurt A Swanson; George P Leser; Reay G Paterson; Robert A Lamb; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

Review 6.  Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis.

Authors:  Chanakha K Navaratnarajah; Alex R Generous; Iris Yousaf; Roberto Cattaneo
Journal:  J Biol Chem       Date:  2020-01-16       Impact factor: 5.157

7.  N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site.

Authors:  Vasiliy P Mishin; Makiko Watanabe; Garry Taylor; John Devincenzo; Michael Bose; Allen Portner; Irina V Alymova
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

8.  Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome.

Authors:  Arthur S Samuel; Anandan Paldurai; Sachin Kumar; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

9.  Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.

Authors:  Irina V Alymova; Garry Taylor; Toru Takimoto; Tsu-Hsing Lin; Pooran Chand; Y Sudhakara Babu; Chenghong Li; Xiaoping Xiong; Allen Portner
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  Loss of the N-linked glycan at residue 173 of human parainfluenza virus type 1 hemagglutinin-neuraminidase exposes a second receptor-binding site.

Authors:  Irina V Alymova; Garry Taylor; Vasiliy P Mishin; Makiko Watanabe; K Gopal Murti; Kelli Boyd; Pooran Chand; Y Sudhakara Babu; Allen Portner
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.